Biotech plans first drug trial, C-suite hiring push after $91M round

Korro Bio has more than $90 million in the bank and a lead drug candidate. What else does it need? A CEO.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.